Search Results - Haskell, Kathleen
- Showing 1 - 5 results of 5
-
1
Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling by She, Qing-Bai, Chandarlapaty, Sarat, Ye, Qing, Lobo, Jose, Haskell, Kathleen M., Leander, Karen R., DeFeo-Jones, Deborah, Huber, Hans E., Rosen, Neal
Published 2008Text -
2
A Strategy for Selective Deletion of Autoimmunity-Related T Cells by pMHC-Targeted Delivery by Goldberg, Shalom D., Felix, Nathan, McCauley, Michael, Eberwine, Ryan, Casta, Lou, Haskell, Kathleen, Lin, Tricia, Palovick, Elizabeth, Klein, Donna, Getts, Lori, Getts, Robert, Zhou, Mimi, Bansal-Pakala, Pratima, Dudkin, Vadim
Published 2021Text -
3
Centyrin ligands for extrahepatic delivery of siRNA by Klein, Donna, Goldberg, Shalom, Theile, Christopher S., Dambra, Richard, Haskell, Kathleen, Kuhar, Elise, Lin, Tricia, Parmar, Rubina, Manoharan, Muthiah, Richter, Mark, Wu, Meizhen, Mendrola Zarazowski, Jeannine, Jadhav, Vasant, Maier, Martin A., Sepp-Lorenzino, Laura, O’Neil, Karyn, Dudkin, Vadim
Published 2021Text -
4
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors by Barnett, Stanley F., Defeo-Jones, Deborah, Fu, Sheng, Hancock, Paula J., Haskell, Kathleen M., Jones, Raymond E., Kahana, Jason A., Kral, Astrid M., Leander, Karen, Lee, Ling L., Malinowski, John, McAVOY, Elizabeth M., Nahas, Debbie D., Robinson, Ronald G., Huber, Hans E.
Published 2005Text -
5
An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo by Cherrin, Craig, Haskell, Kathleen, Howell, Bonnie, Jones, Raymond, Leander, Karen, Robinson, Ronald, Watkins, Aubrey, Bilodeau, Mark, Hoffman, Jacob, Sanderson, Philip, Hartman, George, Mahan, Elizabeth, Prueksaritanont, Thomayant, Jiang, Guoqiang, She, Qing-Bai, Rosen, Neal, Sepp-Lorenzino, Laura, Defeo-Jones, Deborah, Huber, Hans E.
Published 2010Text